The FTC’s newly announced settlement with Express Scripts marks a pivotal moment in the government’s campaign against pharmacy benefit manager pricing practices—and it should be read as more than a ...

Express Scripts agreed to overhaul its business model, ensuring patients pay the lowest available price for medications and ...

The agreement includes sweeping changes for Cigna’s PBM, including no longer preferring expensive drugs over cheaper ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The Federal Trade Commission has paused its settlement review involving Express ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing.

Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...

The FTC settled a lawsuit against Express Scripts over allegations that the company artificially inflated the price of insulin and impeded access to treatment.

You might say that Express Scripts has a bad case of the blues lately. Its stock plummeted in the weeks following a public statement by Anthem, the largest Blue Cross and Blue Shield plan, that it ...

They're the two biggest pharmacy benefits managers in the world, and they compete against each other every day. While CVS Health boasts a higher market cap thanks to its retail pharmacies, Express ...